Douglas A Saltel

Title: The Innovations of Douglas A. Saltel

Introduction

Douglas A. Saltel is an accomplished inventor based in Austin, TX (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of sustained release formulations. His innovative work has led to the creation of a unique pharmaceutical composition that enhances the delivery of lorazepam.

Latest Patents

Douglas A. Saltel holds 1 patent for his invention titled "Sustained release formulations of lorazepam." This patent describes a pharmaceutical composition designed to deliver lorazepam in a prolonged manner. The formulation includes sustained release lorazepam beads and delayed sustained release lorazepam beads, allowing for once-daily dosing that maintains a 24-hour therapeutic effect under steady state conditions.

Career Highlights

Throughout his career, Douglas has focused on advancing pharmaceutical technologies. His work at Edgemont Pharmaceuticals LLC has been pivotal in developing innovative solutions for medication delivery. His expertise in sustained release formulations has positioned him as a key figure in the pharmaceutical industry.

Collaborations

Douglas has collaborated with notable professionals in his field, including Michael G. Vachon and Michael Vachon. These collaborations have contributed to the advancement of his research and the successful development of his patented formulations.

Conclusion

Douglas A. Saltel's contributions to pharmaceutical innovations, particularly in sustained release formulations, highlight his dedication to improving medication delivery systems. His work continues to impact the field positively, showcasing the importance of innovation in healthcare.